MaxCyte Newsroom

BTIG Maintains MaxCyte(MXCT.US) With Buy Rating, Maintains Target Price $8

Futu NewsNov 12 20:35

Stifel Maintains MaxCyte(MXCT.US) With Buy Rating, Maintains Target Price $11

Futu NewsNov 7 23:31

Craig-Hallum Maintains MaxCyte(MXCT.US) With Buy Rating, Announces Target Price $7

Futu NewsNov 7 22:35

TD Cowen Maintains MaxCyte(MXCT.US) With Buy Rating

Futu NewsNov 7 21:39

TD Cowen Initiates MaxCyte(MXCT.US) With Buy Rating

Futu NewsNov 7 09:31

Craig-Hallum Maintains MaxCyte(MXCT.US) With Buy Rating

Futu NewsNov 6 22:32

Craig-Hallum Maintains MaxCyte(MXCT.US) With Buy Rating

Futu NewsNov 5 22:32

Craig-Hallum Maintains MaxCyte(MXCT.US) With Buy Rating

Futu NewsNov 4 22:31

Craig-Hallum Sticks to Its Buy Rating for MaxCyte (MXCT)

TipRanksNov 4 22:12

Deutsche Bank Upgrades MaxCyte(MXCT.US) to Buy Rating, Raises Target Price to $6.78

Futu NewsOct 11 21:33

TD Cowen Maintains MaxCyte(MXCT.US) With Buy Rating

Futu NewsSep 24 19:31

Craig-Hallum Maintains MaxCyte(MXCT.US) With Buy Rating

Futu NewsSep 16 21:31

TD Cowen Maintains MaxCyte(MXCT.US) With Buy Rating

Futu NewsAug 7 12:32

Craig-Hallum Maintains MaxCyte(MXCT.US) With Buy Rating

Futu NewsAug 6 21:32

Craig-Hallum Maintains MaxCyte(MXCT.US) With Buy Rating

Futu NewsAug 5 21:31

MaxCyte Analyst Ratings

BenzingaApr 23 23:25

MaxCyte Analyst Ratings

BenzingaMar 13 20:05

Analysts Offer Insights on Healthcare Companies: MaxCyte (GB:MXCT), Kura Oncology (KURA) and InMode (INMD)

TipRanksJan 23 17:09

Craig-Hallum Initiates Coverage On MaxCyte With Buy Rating, Announces Price Target of $7

BenzingaNov 30, 2023 00:10

MaxCyte Analyst Ratings

BenzingaNov 30, 2023 00:08